Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Anderson

Showing results (311-320 of 378) with videos related to

Pageof 38
Sort By:
Journal of Neuro-Oncology|January 31, 2021
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFRKedar S Vaidya, Michael J Mitten, Adelyn L Zelaya-Lazo, et al.
Journal of Viral Hepatitis|February 22, 2024
High prevalence of hepatitis B virus among MSM living with HIV in IndiaHussain Syed Iqbal, Mihili P Gunaratne, Talia A Loeb, et al.
MMWR. Morbidity and Mortality Weekly Report|March 11, 2021
Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021Moriam Ojelade, Annette Rodriguez, Dante Gonzalez, et al.
Multiple Sclerosis and Related Disorders|April 15, 2023
Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomesGauruv Bose, Brian C Healy, Shrishti Saxena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor functionKatharine D Grugan, Francis L McCabe, Michelle Kinder, et al.
Hepatology Communications|April 3, 2022
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infectionMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Hepatology Communications|September 24, 2021
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based TherapyMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Hepatology Communications|April 7, 2023
Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infectionMary A Rodgers, Pir A Shah, Mark Anderson, et al.
AIDS (London, England)|February 15, 2022
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapyClaudia Hawkins, Minhee Kang, Debika Bhattacharya, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2013
Sulfonyl-polyol N,N-dichloroamines with rapid, broad-spectrum antimicrobial activityTimothy P Shiau, Eddy Low, Bum Kim, et al.
Pageof 38

Showing results (311-320 of 378) with videos related to

Sort By:
Pageof 38
Journal of Neuro-Oncology|January 31, 2021
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFRKedar S Vaidya, Michael J Mitten, Adelyn L Zelaya-Lazo, et al.
Journal of Viral Hepatitis|February 22, 2024
High prevalence of hepatitis B virus among MSM living with HIV in IndiaHussain Syed Iqbal, Mihili P Gunaratne, Talia A Loeb, et al.
MMWR. Morbidity and Mortality Weekly Report|March 11, 2021
Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021Moriam Ojelade, Annette Rodriguez, Dante Gonzalez, et al.
Multiple Sclerosis and Related Disorders|April 15, 2023
Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomesGauruv Bose, Brian C Healy, Shrishti Saxena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor functionKatharine D Grugan, Francis L McCabe, Michelle Kinder, et al.
Hepatology Communications|April 3, 2022
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infectionMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Hepatology Communications|September 24, 2021
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based TherapyMichel Bazinet, Mark Anderson, Victor Pântea, et al.
Hepatology Communications|April 7, 2023
Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infectionMary A Rodgers, Pir A Shah, Mark Anderson, et al.
AIDS (London, England)|February 15, 2022
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapyClaudia Hawkins, Minhee Kang, Debika Bhattacharya, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2013
Sulfonyl-polyol N,N-dichloroamines with rapid, broad-spectrum antimicrobial activityTimothy P Shiau, Eddy Low, Bum Kim, et al.
Pageof 38